SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network (BNAI) is experiencing a powerful surge driven by a recent $2 million deal with Valio Technologies, fueling significant speculation. This news, combined with a low float and substantial short interest, has ignited an intense short squeeze, prompting community discussions around anticipated parabolic runs. Investors are celebrating massive gains, with many holding over the weekend and comparing its potential to past high-flying stocks, while short sellers face considerable pressure.

Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. MyMD-1 is a clinical-stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cytokines. SUPERA-CBD is a synthetic derivative of cannabidiol being developed to treat conditions such as epilepsy, chronic pain, depression, as well as neuroinflammatory and neurodegenerative diseases. The company was founded in 1989 and is headquartered in New York, NY.

Q/C Technologies Inc.

Q/C Technologies Inc. is generating significant buzz due to the recent appointment of OpenAI's Chelsea Voss to its board and the strategic involvement of Martin Shkreli. The community is actively discussing the company's potential as a quantum computing play, with many anticipating substantial price appreciation and a possible short squeeze given its low float. Investors are comparing its current setup to previous high-growth opportunities, fueling excitement for its future trajectory.

Idaho Strategic Resources, Inc. engages in the exploration and development of gold, silver and base metal deposits. It has a portfolio of mineral properties namely: Golden Chest Mine, Murray Gold Belt, Butte Highlands and Central Idaho. The company was founded by Grant Brackebusch on July 18, 1996 and is headquartered in Coeur d'Alene, ID.

Idaho Strategic Resources Inc

Idaho Strategic Resources is trending following recent high-grade rare earth element discoveries at its Lemhi Pass project, aligning with a broader government push for domestic critical mineral production. This substantial potential for strategic resources, combined with its established gold mining operations, fuels community discussion about its significant long-term upside and perceived undervaluation.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network (ROSE) is trending as the community intensely discusses its strategic rebrand and pivot towards "Rose AI," emphasizing its role in privacy-preserving AI and Web3 infrastructure. This focus, underpinned by ongoing grants, partnerships, and advancements with its Sapphire runtime for confidential AI and DeFi, drives conversations about ROSE's strengthened utility. Despite price fluctuations, many view ROSE as a pivotal project in the evolving privacy and AI narratives.

VanEck ETF Trust - VanEck Rare Earth/Strategic Metals ETF

VanEck Rare Earth and Strategic Metals ETF

REMX is trending as heightened geopolitical tensions intensify the global race to secure critical rare earth and strategic metals, crucial for defense, EVs, and AI infrastructure. The community is actively discussing potential breakouts and significant upside, driven by various US and international initiatives to bolster domestic supply chains and reduce reliance on dominant foreign producers.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

Kazia Therapeutics is generating significant buzz following reports of an initial immune-complete response in a late-stage breast cancer patient, exciting the community about the drug's potential in oncology. Investors are also noting a recent substantial financing event, which has bolstered the company's financial stability and Nasdaq compliance. While some express caution due to it being an initial single-patient observation and historical share dilution, many view the progress and anticipated clinical updates as potentially transformative.

Irys is a Layer 1 datachain that unifies onchain data storage and smart contract execution into a single network. Traditional smart contract chains handle financial transactions but lack native primitives for working with data at scale. Traditional datachains handle storage but lack integration with smart contracts. Irys serves both. Irys bridges this gap by unifying storage and execution, making data programmable through IrysVM, its native EVM execution layer. The network offers flexible storage options: users can choose between term storage (temporary, duration-based) or permanent storage (one-time payment for perpetual retention). Both operate at at-cost pricing, made possible by Irys's multi-revenue model that combines storage fees, execution fees, and programmable data transactions. This design allows Irys to remain competitive on price while maintaining economic sustainability. Irys achieves instant data retrieval and infinite horizontal scaling. As demand grows, the network expands capacity by adding validators who prove continuous maintenance of their assigned data partitions. The network's native token, $IRYS, is used for all storage and execution fees, as well as validator staking.

Irys

IRYS is actively trending following its recent availability on a major exchange, sparking a surge in trading volume and public awareness. Community sentiment is mixed, with many bullish traders highlighting its "low supply, high demand" and deflationary tokenomics, while others express caution regarding price volatility and suspected bot activity. Investors are discussing its potential in the broader context of programmable data chains and AI-related crypto trends.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar and sustainability. The company was founded in 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E is trending due to significant infrastructure modernization plans, including a multi-billion dollar initiative to meet surging data center energy demand in California. Community sentiment is mixed, with many investors viewing the stock as undervalued given positive developments in wildfire liability management and recent financial performance, while others remain cautious regarding past challenges.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is trending due to advancements in its anticoagulation pipeline, including the Phase 3-ready tecarfarin with FDA Fast Track status and the recent acquisition of VLX-1005 for heparin-induced thrombocytopenia. Community sentiment is sharply divided, with supporters emphasizing the large market opportunity and collaborations like that with Abbott, while detractors express concerns over frequent offerings, cash burn, and perceived promotional activity.

AABG Token

AABBG is actively trending as its community eagerly anticipates the launch of the new AABB Wallet and the silver-backed AABBS token, alongside increasing global gold and silver prices. Investors are also heavily focused on a recently filed federal lawsuit against market makers, alleging widespread securities fraud and manipulation, fueling strong conviction about a potential short squeeze and significant future returns for the resource-rich company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
